Association between age-related reductions in testosterone and risk of prostate cancer-An analysis of patients' data with prostatic diseases

Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer

(2017) Antonio Benito Porcaro et al.   UROLOGIA INTERNATIONALIS

5-Alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial

(2016) Teemu J. Murtola et al.   INTERNATIONAL JOURNAL OF CANCER

Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System

(2016) Antonio Benito Porcaro et al.   UROLOGIA INTERNATIONALIS

Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model

(2015) Xiaohui Xu et al.   BMC CANCER

Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

(2015) Jeannette M. Schenk et al.   CANCER CAUSES & CONTROL

Abstract LB-126: Declining T levels provide increased opportunity for mutagenesis in prostate stem cells

(2015) Ye Zhou et al.   CANCER RESEARCH

Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries

(2015) Ahmad Haider et al.   JOURNAL OF UROLOGY

Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer

(2015) Jacques Baillargeon et al.   JOURNAL OF UROLOGY

The Relationship between Total Testosterone Levels and Prostate Cancer: A Review of the Continuing Controversy

(2015) Julia Klap et al.   JOURNAL OF UROLOGY

Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading

(2015) A Pichon et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Prostate cancer stem cells: the role of androgen and estrogen receptors

(2015) Erika Di Zazzo et al.   Oncotarget

Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer

(2014) Esra Guzel et al.   INTERNATIONAL JOURNAL OF CANCER

Androgens and androgen receptor signaling in prostate tumorigenesis

(2014) Ye Zhou et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

PSA velocity: A systematic review of clinical applications

(2014) Kevin Raymond Loughlin   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer

(2013) Joachim Weischenfeldt et al.   CANCER CELL

Testosterone: a metabolic hormone in health and disease

(2013) Daniel M Kelly et al.   JOURNAL OF ENDOCRINOLOGY

Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue

(2013) Ye Zhou et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial

(2012) Roberto L. Muller et al.   EUROPEAN UROLOGY

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer

(2011) A Urbanucci et al.   ONCOGENE

Low serum testosterone levels are predictive of prostate cancer

(2011) Luigi Mearini et al.   WORLD JOURNAL OF UROLOGY

The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model

(2010) Steffen E Eikenberry et al.   Biology Direct

Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men

(2010) Frederick C.W. Wu et al.   NEW ENGLAND JOURNAL OF MEDICINE